European Medicines Agency welcomes continuation of D:A:D study

View source ↗

Summary

EMA welcomes the continuation of the D:A:D study, a long-running observational study related to antiretroviral therapy and potential health outcomes. The announ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• D:A:D study